ArticleEpilepsy & behavior reports2022

The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma.

Anh Huan Vo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.